标题
Targeting cell cycle and hormone receptor pathways in cancer
作者
关键词
-
出版物
ONCOGENE
Volume 32, Issue 48, Pages 5481-5491
出版商
Springer Nature
发表日期
2013-05-27
DOI
10.1038/onc.2013.83
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
- (2012) J. P. Leonard et al. BLOOD
- Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors
- (2012) M. M. Centenera et al. CLINICAL CANCER RESEARCH
- Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
- (2012) Patrick J. Roberts et al. JNCI-Journal of the National Cancer Institute
- Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
- (2011) G K Schwartz et al. BRITISH JOURNAL OF CANCER
- Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family
- (2011) Paula Rodriguez-Otero et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
- (2011) Lars Anders et al. CANCER CELL
- Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma
- (2011) A. Ismail et al. CLINICAL CANCER RESEARCH
- Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
- (2011) K. T. Flaherty et al. CLINICAL CANCER RESEARCH
- Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features
- (2011) V. Tzelepi et al. CLINICAL CANCER RESEARCH
- [18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells
- (2011) Cathy C. Zhang et al. CLINICAL CANCER RESEARCH
- Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
- (2011) Gottfried E. Konecny et al. CLINICAL CANCER RESEARCH
- Pharmacotherapeutic Management of Locally Advanced Prostate Cancer
- (2011) Jarad M. Martin et al. DRUGS
- Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
- (2011) C. Thangavel et al. ENDOCRINE-RELATED CANCER
- mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer
- (2011) Matthew J Schiewer et al. ENDOCRINE-RELATED CANCER
- New Hormonal Therapies for Castration-Resistant Prostate Cancer
- (2011) Elahe A. Mostaghel et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Cyclin D1 Is a Selective Modifier of Androgen-dependent Signaling and Androgen Receptor Function
- (2011) Clay E. S. Comstock et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Common Gene Rearrangements in Prostate Cancer
- (2011) Mark A. Rubin et al. JOURNAL OF CLINICAL ONCOLOGY
- The AR dependent cell cycle: Mechanisms and cancer relevance
- (2011) Matthew J. Schiewer et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- A Robust High-Content Imaging Approach for Probing the Mechanism of Action and Phenotypic Outcomes of Cell-Cycle Modulators
- (2011) J. J. Sutherland et al. MOLECULAR CANCER THERAPEUTICS
- A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
- (2011) Siwanon Jirawatnotai et al. NATURE
- Time to stratify? The retinoblastoma protein in castrate-resistant prostate cancer
- (2011) Ana Aparicio et al. Nature Reviews Urology
- A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer
- (2011) D M Heijink et al. ONCOGENE
- ER -Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer
- (2011) T. W. Miller et al. Cancer Discovery
- A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma
- (2010) Marta Puyol et al. CANCER CELL
- Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts
- (2010) K. Michaud et al. CANCER RESEARCH
- Cyclin D2-Cyclin-Dependent Kinase 4/6 Is Required for Efficient Proliferation and Tumorigenesis following Apc Loss
- (2010) A. M. Cole et al. CANCER RESEARCH
- Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors
- (2010) Neil Johnson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Proliferative Suppression by CDK4/6 Inhibition: Complex Function of the Retinoblastoma Pathway in Liver Tissue and Hepatoma Cells
- (2010) Dayana B. Rivadeneira et al. GASTROENTEROLOGY
- Whether to target single or multiple CDKs for therapy? That is the question
- (2010) Józefa Węsierska-Gądek et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
- (2010) Ankur Sharma et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
- (2010) J L Dean et al. ONCOGENE
- Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM
- (2010) W. R. Wiedemeyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The E2F1/Rb and p53/MDM2 Pathways in DNA Repair and Apoptosis: Understanding the Crosstalk to Develop Novel Strategies for Prostate Cancer Radiotherapy
- (2010) Thirupandiyur Udayakumar et al. SEMINARS IN RADIATION ONCOLOGY
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Cyclin-dependent kinase inhibitors as potential targeted anticancer agents
- (2009) Ivan Diaz-Padilla et al. INVESTIGATIONAL NEW DRUGS
- Treatment of Growing Teratoma Syndrome
- (2009) David J. Vaughn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of human CDK4 in complex with a D-type cyclin
- (2009) P. J. Day et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel Therapeutic Combination Using PD 0332991 and Bortezomib: Study in the 5T33MM Myeloma Model
- (2008) E. Menu et al. CANCER RESEARCH
- Advancing Bioluminescence Imaging Technology for the Evaluation of Anticancer Agents in the MDA-MB-435-HAL-Luc Mammary Fat Pad and Subrenal Capsule Tumor Models
- (2008) C. Zhang et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started